Frederick Gluck
About Frederick Gluck
Frederick W. Gluck is based in Moorpark, California. He worked at McKinsey & Company from 1967 to 1995 and was its managing director (chief executive) from 1988 to 1994. Before McKinsey he worked at Bell Laboratories. From 1994 to 1998 he was vice chairman and a director at the Bechtel Group, then returned to McKinsey as a consultant until 2003.
He holds a B.S. in electrical engineering from Manhattan College and an M.S. in the same field from New York University. He has served on the boards of Amgen and HCA, and on nonprofit boards including Cottage Health System and the UCSB Foundation. He also endowed the Frederick W. Gluck Chair in Theoretical Physics at the Kavli Institute for Theoretical Physics.
After McKinsey he co-founded CytomX, a cancer-focused technology company, and was its chairman and CEO from 2006 to 2008. In 2008 the company spun off Cynvenio Biosystems, which was renamed LungLife AI in 2019. He stayed chairman of both. He served on the CytomX board from its 2008 founding until he retired from it effective June 30, 2022.
Crunchbase lists one personal investment for Gluck: a Series A round in Guru. The date, round size and his check size are not public. Crunchbase shows 1 portfolio company, 0 lead investments and 1 exit (0 by IPO). He is better documented as a founder and board member than as a frequent angel.
No AI angel investments are publicly documented. His AI link is LungLife AI, which develops lung cancer diagnostics enhanced by AI and is listed on the London Stock Exchange (LON: LLAI) after a July 2021 IPO. Company filings show he resigned as a director on 1 July 2021 and remained a shareholder. The company's shareholder page lists him with 1,757,353 shares, or 5.7%.
Gluck has not published a thesis, preferred stage or check size. His own company building has been in medical technology and diagnostics, with roots in UC Santa Barbara research. That is a record as a founder and chairman, not a stated investment focus. Founders should treat him as a possible fit only for healthcare or diagnostics AI, or for questions on scaling an organization and strategy, given his McKinsey and Bechtel background.
- Guru: the one investment Crunchbase lists for him, a Series A round. The date and amount are not public.
- LungLife AI: AI-enhanced lung cancer diagnostics. Co-founder and former chairman, and a shareholder.
- CytomX Therapeutics: oncology therapeutics company. Co-founder of the predecessor company and a board member from 2008 to 2022.
- crunchbase.com/person/fred-gluck
- crunchbase.com/organization/cynvenio-biosystems
- en.wikipedia.org/wiki/Frederick_Gluck
- safewaternetwork.org/news/frederick-gluck-former-head-mckinsey-company
- finance.yahoo.com/news/cytomx-therapeutics-announces-retirement-freder
- kitp.ucsb.edu/directors-council-members/fred-gluck
- kitp.ucsb.edu/news/gluck-endows-chair-theoretical-physics-institute-di
- lunglifeai.com/investors/shareholder-information
Investing activity
Frederick Gluck has made 1 investment according to Crunchbase across 1 portfolio company, and has seen 1 exit and founded 2 companies.
Deals
Frequently asked questions about Frederick Gluck
Is Frederick Gluck an active angel investor?
Crunchbase lists one personal investment, a Series A in Guru, with no public date. There is no public record of a regular angel program.
What is Frederick Gluck's check size?
It is not public. No source gives a check size or investing range for him.
What companies has Frederick Gluck founded?
He co-founded CytomX, the predecessor of CytomX Therapeutics, and LungLife AI, which was formerly Cynvenio Biosystems. He was chairman of both.
Does Frederick Gluck invest in AI startups?
No AI angel investments are documented. He co-founded LungLife AI, which applies AI to lung cancer diagnostics, and he still holds shares in it.
What is Frederick Gluck's professional background?
He was managing director of McKinsey & Company from 1988 to 1994 and vice chairman of the Bechtel Group from 1994 to 1998. He has served on the Amgen and HCA boards.
Where is Frederick Gluck based?
Lounge lists him in Moorpark, California. Crunchbase has also shown Westlake Village, and LungLife AI is headquartered in Thousand Oaks.
Is Frederick Gluck an angel investor?
Yes. Frederick Gluck invests personally as an angel and is Co-Founder at LungLife AI. Crunchbase counts 1 investment and 1 exit.
How can founders reach Frederick Gluck?
Founders on Lounge can see Frederick Gluck's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with them under Warm Paths, and add Frederick Gluck to their Investor Pipeline to track the conversation.